Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Categories
Countries
ANIMAL HEALTH MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 123 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 123 pages
- Published: 02-11-2019
The global animal health market was worth more than US$ 44 Billion in 2018. Animals regularly require adequate care from their owners in order to have a good health. As the production of healthy livestock ensures safe food supply and retains the stability of consumer prices, regular monitoring of animal health and averting animal disease outbreaks have become indispensable for every country. As effective control and prevention is necessary for limiting the spread of zoonotic diseases among animals and human beings, the animal health market is gradually gaining traction across the globe. Moreover, pet and livestock owners nowadays are willing to spend on animal healthcare products and services owing to their inflating disposable incomes, growing awareness through print and electronic media, and the emerging trend of pet humanization.
Global Animal Health Market Drivers:
Currently, the animal health industry is flourishing on account of rapid technological advancements and increasing research and development activities in the veterinary pharmaceutical industry. With the help of advanced technological systems, data produced in veterinary clinics can be now uploaded on the internet and shared with other researchers and clinicians. This technology also aids in facilitating real-time analysis of fluctuations in the prevalence of diseases. In order to optimize the veterinary healthcare sector, governments in several developed countries are also undertaking initiatives and implementing animal vaccination programs. On account of these factors, the market value is projected to exceed US$ 58 Billion by 2024, exhibiting a CAGR of around 5% during 2019-2024.
Breakup by Animal Type:
On the basis of animal types, the market has been bifurcated into commercial and companion animals. At present, commercial animals account for the majority of the market share.
Breakup by Product Type:
Based on the product type, the animal health market has been divided into pharmaceuticals, biologicals, medicinal feed additives and diagnostics. Pharmaceuticals currently represent the largest product type.
Regional Insights:
On a geographical front, North America enjoys the leading position in the global animal health market. Other regions include Europe, Asia Pacific, Latin America, and Middle East and Africa.
Competitive Landscape:
The market is highly fragmented in nature with the presence of several small as well as large players who compete in terms of prices and quality. Some of the major players operating in the market include:
Bayer
Elanco
Merck
Merial
Zoetis Inc.
Biogenesis Bago
Boehringer Ingelheim
Ceva Sante Animale
Heska
Neogen
Novartis
Thermo Fisher Scientific
Vetoquinol
Virbac
Key Questions Answered in This Report:
- How has the global animal health market performed so far and how will it perform in the coming years?
- What are the key regions in the global animal health market?
- Which are the popular animal types in the global animal health market?
- What are the key product types in the global animal health market?
- What are the various stages in the value chain of the global animal health market?
- What are the key driving factors and challenges in the global animal health market?
- What is the structure of the global animal health market and who are the key players?
- What is the degree of competition in the global animal health market?
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Key Industry Trends 5. Global Animal Health Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Animal Type 5.4 Market Breakup by Product 5.5 Market Breakup by Region 5.6 Market Forecast 6. Market Breakup by Animal Type 6.1 Commercial 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Companion 6.2.1 Market Trends 6.2.3 Market Forecast 7. Market Breakup by Product 7.1 Pharmaceuticals 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Biologicals 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Medicinal Feed Additives 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Diagnostics 7.4.1 Market Trends 7.4.2 Market Forecast 8. Market Breakup by Region 8.1 North America 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Europe 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Asia Pacific 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Middle East and Africa 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Latin America 8.5.1 Market Trends 8.5.2 Market Forecast 9. Global Animal Health Industry: SWOT Analysis 9.1 Overview 9.2 Strengths 9.3 Weaknesses 9.4 Opportunities 9.5 Threats 10. Global Animal Health Industry: Value Chain Analysis 11. Global Animal Health Industry: Porters Five Forces Analysis 11.1 Overview 11.2 Bargaining Power of Buyers 11.3 Bargaining Power of Suppliers 11.4 Degree of Competition 11.5 Threat of New Entrants 11.6 Threat of Substitutes 12. Global Animal Health Industry: Price Analysis 12.1 Price Indicators 12.2 Price Structure 12.3 Margin Analysis 13. Competitive Landscape 13.1 Market Structure 13.2 Key Players 13.3 Profiles of Key Players 13.3.1 Bayer 13.3.2 Elanco 13.3.3 Merck 13.3.4 Merial 13.3.5 Zoetis Inc. 13.3.6 Biogenesis Bago 13.3.7 Boehringer Ingelheim 13.3.8 Ceva Sante Animale 13.3.9 Heska 13.3.10 Neogen 13.3.11 Novartis 13.3.12 Thermo Fisher Scientific 13.3.13 Vetoquinol 13.3.14 Virbac |
Market Breakup by Animal Type
- Commercial
- Companion
Market Breakup by Product
- Pharmaceuticals
- Biologicals
- Medicinal Feed Additives
- Diagnostics
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
ANALGESICS MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 102 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 102 pages
- Published: 02-11-2019
The global analgesics market was worth US$ 44.3 Billion in 2018. Pain currently represents a major global health challenge. Worldwide, it has been estimated that 1 out of every 5 adults suffers from pain and that another 1 in in every 10 adults are diagnosed with chronic pain each year. Analgesics (also known as painkillers or pain relievers) are drugs that are taken to relieve pain. They may be taken to relieve pain that arises from a wide range of conditions, such as appendicitis, surgery, infection, headaches, mensuration, cancer, pain syndromes, sprains, strains, toothache, etc. The two major categories of analgesics that are used to treat pain include Opioids and NSAIDs. Majority of the analgesics are taken orally. They may, however, also be taken through other delivery routes such as parenteral, topical, transdermal, rectal, etc.
The global analgesics market is expected to exhibit moderate growth over the next five years. A major factor catalyzing this demand is the strong growth in the geriatric population. In 2017, between 950 Million-1000 Million people were over the age of 60. We expect these numbers to reach 2100 Million by 2050 accounting for 21% of the total global population. The rising older population is expected to increase the incidence of pain arising from a number of chronic and lifestyle diseases. The market for analgesics is also expected to be catalyzed by a strong drug pipeline and high unmet needs. We expect a number of new drugs to be launched in the coming years. Other major factors catalyzing the analgesics market include changing lifestyles, rising prevalence of obesity and overweight, rising prevalence of chronic diseases, etc. Looking forward, the global analgesics market is expected to reach a revenue of US$ 56.8 Billion by 2024, exhibiting a CAGR of around 4% during 2019-2024.
Market Summary:
Based on the drug type, the market has been segmented into prescription analgesics and OTC analgesics. Prescription analgesics currently dominate the market, holding the largest share.
Based on the drug class, the market has been segmented into opioids, NSAIDs and others. Opioids currently represents the biggest segment.
Based on the route of administration, the market has been segmented into oral, parenteral, topical, transdermal and rectal. Currently, oral dominates the market, holding the largest share.
Based on the pain type, the market has been segmented into musculoskeletal pain, surgical and trauma pain, cancer pain, neuropathic pain, migraine, obstetrical pain, fibromyalgia, pain due to burns, dental/facial pain, paediatric pain and others. Musculoskeletal pain currently represents the biggest segment.
Based on the application, the market has been segmented into internal analgesics and external analgesics. Internal analgesics currently represent the biggest segment.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. North America currently represents the biggest market.
The competitive landscape of the market has also been examined with some of the key players being Bayer AG, Novartis AG, GlaxoSmithKline PLC, Pfizer Inc., Johnson & Johnson, Reckitt Benckiser (RB), Endo Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi, etc.
Key Questions Answered in This Report:
- How has the global analgesics market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global analgesics industry?
- What is the breakup of the global analgesics market on the basis of drug type?
- What is the breakup of the global analgesics market on the basis of drug class?
- What is the breakup of the global analgesics market on the basis of route of administration?
- What is the breakup of the global analgesics market on the basis of pain type?
- What is the breakup of the global analgesics market on the basis of application?
- What are the various stages in the value chain of the global analgesics market?
- What are the key driving factors and challenges in the global analgesics market?
- What is the structure of the global analgesics market and who are the key players?
- What is the degree of competition in the global analgesics market?
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Properties 4.3 Key Industry Trends 5. Global Analgesics Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Type 5.4 Market Breakup by Drug Class 5.5 Market Breakup by ROA 5.6 Market Breakup by Pain Type 5.7 Market Breakup by Application 5.8 Market Breakup by Region 5.9 Market Forecast 6. Market Breakup by Type 6.1 Prescription Analgesics 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 OTC Analgesics 6.2.1 Market Trends 6.2.2 Market Forecast 7. Market Breakup by Drug Class 7.1 Opioids 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 NSAID 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Others 7.3.1 Market Trends 7.3.2 Market Forecast 8. Market Breakup by ROA 8.1 Oral 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Parenteral 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Topical 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Transdermal 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Rectal 8.5.1 Market Trends 8.5.2 Market Forecast 9. Market Breakup by Pain Type 9.1 Musculoskeletal Pain 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Surgical and Trauma Pain 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Cancer Pain 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Neuropathic Pain 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Migraine 9.5.1 Market Trends 9.5.2 Market Forecast 9.6 Obstetrical Pain 9.6.1 Market Trends 9.6.2 Market Forecast 9.7 Fibromyalgia 9.7.1 Market Trends 9.7.2 Market Forecast 9.8 Pain due to Burns 9.8.1 Market Trends 9.8.2 Market Forecast 9.9 Dental/Facial Pain 9.9.1 Market Trends 9.9.2 Market Forecast 9.10 Pediatric Pain 9.10.1 Market Trends 9.10.2 Market Forecast 9.11 Others 9.11.1 Market Trends 9.11.2 Market Forecast 10. Market Breakup by Application 10.1 Internal Analgesics 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 External Analgesics 10.2.1 Market Trends 10.2.2 Market Forecast 11. Market Breakup by Region 11.1 North America 11.1.1 Market Trends 11.1.2 Market Forecast 11.2 Europe 11.2.1 Market Trends 11.2.2 Market Forecast 11.3 Asia Pacific 11.3.1 Market Trends 11.3.2 Market Forecast 11.4 Middle East and Africa 11.4.1 Market Trends 11.4.2 Market Forecast 11.5 Latin America 11.5.1 Market Trends 11.5.2 Market Forecast 12. Global Analgesics Industry: SWOT Analysis 12.1 Overview 12.2 Strengths 12.3 Weaknesses 12.4 Opportunities 12.5 Threats 13. Global Analgesics Industry: Value Chain Analysis 13.1 Overview 13.2 Research and Development 13.3 Raw Material Procurement 13.4 Manufacturing 13.5 Marketing 13.6 Distribution 13.7 End-Use 14. Global Analgesics Industry: Porters Five Forces Analysis 14.1 Overview 14.2 Bargaining Power of Buyers 14.3 Bargaining Power of Suppliers 14.4 Degree of Competition 14.5 Threat of New Entrants 14.6 Threat of Substitutes 15. Global Analgesics Industry: Price Analysis 15.1 Price Indicators 15.2 Price Structure 15.3 Margin Analysis 16. Competitive Landscape 16.1 Market Structure 16.2 Key Players 16.3 Profiles of Key Players 16.3.1 Bayer AG 16.3.2 Novartis AG 16.3.3 GlaxoSmithKline PLC 16.3.4 Pfizer Inc. 16.3.5 Johnson & Johnson 16.3.6 Reckitt Benckiser (RB) 16.3.7 Endo Pharmaceuticals 16.3.8 Bristol-Myers Squibb 16.3.9 Eli Lilly and Company 16.3.10 Sanofi |
Market Breakup by Type
- Prescription Analgesics
- OTC Analgesics
Market Breakup by Drug Class
- Opioids
- NSAID
- Others
Market Breakup by ROA
- Oral
- Parenteral
- Topical
- Transdermal
- Rectal
Market Breakup by Pain Type
- Musculoskeletal Pain
- Surgical and Trauma Pain
- Cancer Pain
- Neuropathic Pain
- Migraine
- Obstetrical Pain
- Fibromyalgia
- Pain due to Burns
- Dental/Facial Pain
- Pediatric Pain
- Others
Market Breakup by Application
- Internal Analgesics
- External Analgesics
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 151 pages | Published: 02-11-2019 |
- Healthcare
- IMARC GROUP
- 151 pages
- Published: 02-11-2019
The global active pharmaceutical ingredients market was worth US$ 176.3 Billion in 2018. Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as “excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription.
Pharmaceutical manufacturing occurs in two general steps. In the first step, manufacturers convert raw materials into APIs. The second step involves creating the final formulation by mixing APIs and excipients into tablets, capsules, solutions, etc. and finally packaging the drug for the end users. Manufacturers either sell APIs in the open market (also known as the merchant market) or use them as inputs to make their final formulations. The global API market is extremely competitive with a number of large and small manufacturers. Firms that engage in API manufacturing generally specialize and target their manufacturing based on a combination of the firms in-house skills and market opportunities. Catalyzed by lower costs, API manufacturing has gradually been shifting from the historical leaders in Western countries to manufacturers based in India and China.
The global demand of APIs is currently exhibiting strong growth. One of the major drivers of this market is the rising number of blockbuster patent expiries creating a significant opportunity for generic APIs. Moreover, there has been a strong demand for APIs for biologicals. The global market for biologicals is currently exhibiting strong growth catalyzed by their high potency and ability to treat diseases beyond the scope of small molecule drugs. This is creating a strong demand for APIs for branded biological drugs and their biosimilar versions. Other factors catalyzing the global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc. Looking forward, the market value is projected to reach US$ 247.2 Billion by 2024, exhibiting a CAGR of 5.8% during 2019-2024.
Market Summary:
Based on the drug type, the market has been segmented as innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients.
Based on the type of manufacturer, the market has been segmented as captive manufacturers and merchant API manufacturers.
Based on the type of synthesis, the market has been segmented as synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients.
Based on the therapeutic application, the market has been segmented as oncology, cardiovascular disease, diabetes, central nervous system and neurological disorders, endocrinology and others.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The competitive landscape of the market has also been examined with some of the key players being Pfizer, Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., ELI Lilly and Company, GlaxoSmithKline, Merck & Co., Inc. and Abbvie Inc.
Key Questions Answered in This Report:
- How has the global active pharmaceutical ingredients market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global active pharmaceutical ingredients industry?
- What is the breakup of the global active pharmaceutical ingredients market on the basis of drug type?
- What is the breakup of the global active pharmaceutical ingredients market on the basis of type of manufacturer?
- What is the breakup of the global active pharmaceutical ingredients market on the basis of synthesis?
- What is the breakup of the global active pharmaceutical ingredients market on the basis of therapeutic application?
- What are the various stages in the value chain of the global active pharmaceutical ingredients market?
- What are the key driving factors and challenges in the global active pharmaceutical ingredients market?
- What is the structure of the global active pharmaceutical ingredients market and who are the key players?
- What is the degree of competition in the global active pharmaceutical ingredients market?
- How are active pharmaceutical ingredients manufactured?
| 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Active Pharmaceutical Ingredients Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Drug Type 5.4 Market Breakup by Type of Manufacturer 5.5 Market Breakup by Type of Synthesis 5.6 Market Breakup by Therapeutic Application 5.7 Market Breakup by Region 5.8 Market Forecast 5.9 SWOT Analysis 5.9.1 Overview 5.9.2 Strengths 5.9.3 Weaknesses 5.9.4 Opportunities 5.9.5 Threats 5.10 Value Chain Analysis 5.11 Porters Five Forces Analysis 5.11.1 Overview 5.11.2 Bargaining Power of Buyers 5.11.3 Bargaining Power of Suppliers 5.11.4 Degree of Competition 5.11.5 Threat of New Entrants 5.11.6 Threat of Substitutes 5.12 Price Analysis 5.12.1 Price Indicators 5.12.2 Price Structure 5.12.3 Margin Analysis 6 Market Breakup by Drug Type 6.1 Innovative Active Pharmaceutical Ingredients 6.2 Generic Active Pharmaceutical Ingredients 7 Market Breakup by Type of Manufacturer 7.1 Captive Manufacturers 7.2 Merchant API Manufacturers 7.2.1 Innovative Merchant API Manufacturers 7.2.2 Generic Merchant API Manufacturers 8 Market Breakup by Type of Synthesis 8.1 Synthetic Active Pharmaceutical Ingredients 8.1.1 Market Breakup by Type 8.1.1.1 Innovative Synthetic APIs 8.1.1.2 Generic Synthetic APIs 8.2 Biotech Active Pharmaceutical Ingredients 8.2.1 Market Breakup by Type 8.2.1.1 Innovative Biotech APIs 8.2.1.2 Biosimilars 8.2.2 Market Breakup By Product 8.2.2.1 Monoclonal Antibodies 8.2.2.2 Vaccines 8.2.2.3 Cytokines 8.2.2.4 Fusion Proteins 8.2.2.5 Therapeutic Enzymes 8.2.2.6 Blood Factors 8.2.3 Market Breakup By Expression System 8.2.3.1 Mammalian Expression Systems 8.2.3.2 Microbial Expression Systems 8.2.3.3 Yeast Expression Systems 8.2.3.4 Plant Expression Systems 8.2.3.5 Insect Expression Systems 9 Market Breakup by Therapeutic Application 9.1 Oncology 9.2 Cardiovascular Disease 9.3 Diabetes 9.4 Central Nervous System and Neurological Disorders 9.5 Endocrinology 9.6 Others 10 Market Breakup by Region 10.1 North America 10.2 Europe 10.3 Asia Pacific 10.4 Middle East and Africa 10.5 Latin America 11 Manufacturing Process 11.1 Product Overview 11.2 Raw Material Requirements 11.3 Manufacturing Process 11.4 Key Success and Risk Factors 12 Competitive Landscape 12.1 Market Structure 12.2 Key Players 12.3 Profiles of Key Players 12.3.1 Pfizer, Inc. 12.3.2 Novartis International AG 12.3.3 Sanofi 12.3.4 Boehringer Ingelheim 12.3.5 Bristol-Myers Squibb 12.3.6 Teva Pharmaceutical Industries Ltd. 12.3.7 ELI Lilly and Company 12.3.8 GlaxoSmithKline 12.3.9 Merck & Co., Inc. 12.3.10 Abbvie Inc. |
Market Breakup by Drug Type
Innovative Active Pharmaceutical Ingredients
Generic Active Pharmaceutical Ingredients
Market Breakup by Type of Manufacturer
Captive Manufacturers
Merchant API Manufacturers
Innovative Merchant API Manufacturers
Generic Merchant API Manufacturers
Market Breakup by Type of Synthesis
Synthetic Active Pharmaceutical Ingredients
Market Breakup by Type
Innovative Synthetic APIs
Generic Synthetic APIs
Biotech Active Pharmaceutical Ingredients
Market Breakup by Type
Innovative Biotech APIs
Biosimilars
Market Breakup By Product
Monoclonal Antibodies
Vaccines
Cytokines
Fusion Proteins
Therapeutic Enzymes
Blood Factors
Market Breakup By Expression System
Mammalian Expression Systems
Microbial Expression Systems
Yeast Expression Systems
Plant Expression Systems
Insect Expression Systems
Market Breakup by Therapeutic Application
Oncology
Cardiovascular Disease
Diabetes
Central Nervous System and Neurological Disorders
Endocrinology
Others
Market Breakup by Region
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
ACCELERATOR PEDAL MODULE MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Healthcare | Published by: IMARC GROUP | Market: |
| 105 pages | Published: 04-08-2019 |
- Healthcare
- IMARC GROUP
- 105 pages
- Published: 04-08-2019
The global accelerator pedal module market reached a volume of around 360 million units in 2018. Accelerator pedals are a component of accelerators that are used to regulate the supply of fuel into the combustion chamber. They are ready-to-install units consisting of pedal-travel sensor, and idle and full-load stops. They use sensors to detect the amount of pedal depression and transfer the signal to the engine control unit (ECU). The pedal travel sensor also records the movement and position of the accelerator pedal. The ECU uses this information to calculate the required torque and addresses the throttle device and the injection system. Looking forward, IMARC Group expects the market volumes to reach 438 Million units by 2024, registering a CAGR of around 3% during 2019-2024.
Global Accelerator Pedal Module Market Drivers:
The earlier versions of these module were mostly made of metal and covered with rubber which not only made them heavy but also increased the possibility of corrosion. Nowadays, manufacturers are focusing on developing lightweight components for vehicles owing to the stringent government rules to meet emission standards. The advancements in material development technology have further led to the production of accelerator pedals from polyamide 6 which is lightweight and cost effective in nature.
The developed regions such as North America and Europe have a concentration of the world’s largest automotive manufacturers which have access to more developed equipment, strong R&D capabilities and modern technical expertise. As a result, mechanical accelerators have been completely replaced by electronic accelerator pedals in these regions. Additionaly, the increasing use of sensor-based accelerators is expected to be a major driving factor for the growth of the market.
With the rapid development and industrialization in Asia, Africa and the Middle East, the automotive industry has been experiencing healthy growth. The increasing demand for automotive accelerator pedal modules for the manufacturing of passenger cars and commercial vehicles in these regions is providing a positive thrust to the growth of the overall market.
Report Coverage:
Historical, Current and Future Market Trends
Breakup by Pedal Material:
Plastic
Metal
Breakup by Pedal Type:
Floor Mounted
Suspended
Breakup by Vehicle Type:
Passenger Vehicle
Commercial Vehicle
Breakup by End-User:
OEM
Aftermarket
Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Bosch, Denso, ZF, HELLA, United Automotive Electronic Systems, F-TECH, Aisan Industry, Yorozu, Pacific Industrial, Mikuni, Kyung Chang Industrial, TT Electronics, Alfmeier Praezision, Aida Manufacture, AKITA KOGYO, Bellsonica, Chiyoda Industries, Chiyoda Kogyo Kyushu, Daiichi Kogyo, Enoki, Hanya Seisakusho, Kuroda Kagaku, etc.
Key Questions Answered in This Report:
- How has the global accelerator pedal module market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global accelerator pedal module industry?
- What is the breakup of the market based on the pedal material?
- What is the breakup of the market based on the pedal type?
- What is the breakup of the market based on the vehicle type?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the global accelerator pedal module industry?
- What are the key driving factors and challenges in the global accelerator pedal module industry?
- What is the structure of the global accelerator pedal module industry and who are the key players?
- What is the degree of competition in the global accelerator pedal module industry?
- What are the profit margins in the global accelerator pedal module industry?
| 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Accelerator Pedal Module Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Pedal Material 5.4 Market Breakup by Pedal Type 5.5 Market Breakup by Vehicle Type 5.6 Market Breakup by End-User 5.7 Market Breakup by Region 5.8 Market Forecast 6 Market Breakup by Pedal Material 6.1 Plastic 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Metal 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Pedal Type 7.1 Floor Mounted 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Suspended 7.2.1 Market Trends 7.2.2 Market Forecast 8 Market Breakup by Vehicle Type 8.1 Passenger Vehicle 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Commercial Vehicle 8.2.1 Market Trends 8.2.2 Market Forecast 9 Market Breakup by End-User 9.1 OEM 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Aftermarket 9.2.1 Market Trends 9.2.2 Market Forecast 10 Market Breakup by Region 10.1 Europe 10.1.1 Market Trends 10.1.2 Market Forecast 10.2 North America 10.2.1 Market Trends 10.2.2 Market Forecast 10.3 Asia Pacific 10.3.1 Market Trends 10.3.2 Market Forecast 10.4 Middle East and Africa 10.4.1 Market Trends 10.4.2 Market Forecast 10.5 Latin America 10.5.1 Market Trends 10.5.2 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Price Analysis 15 Competitive Landscape 15.1 Market Structure 15.2 Key Players 15.3 Profiles of Key Players 15.3.1 Bosch 15.3.2 Denso 15.3.3 ZF 15.3.4 HELLA 15.3.5 United Automotive Electronic Systems 15.3.6 F-TECH 15.3.7 Aisan Industry 15.3.8 Yorozu 15.3.9 Pacific Industrial 15.3.10 Mikuni 15.3.11 Kyung Chang Industrial 15.3.12 TT Electronics 15.3.13 Alfmeier Praezision 15.3.14 Aida Manufacture 15.3.15 AKITA KOGYO 15.3.16 Bellsonica 15.3.17 Chiyoda Industries 15.3.18 Chiyoda Kogyo Kyushu 15.3.19 Enoki 15.3.20 Hanya Seisakusho 15.3.21 Kuroda Kagaku |
Market Breakup by Pedal Material
- Plastic
- Metal
Market Breakup by Pedal Type
- Floor Mounted
- Suspended
Market Breakup by Vehicle Type
- Passenger Vehicle
- Commercial Vehicle
Market Breakup by End-User
- OEM
- Aftermarket
Market Breakup by Region
- Europe
- North America
- Asia Pacific
- Middle East and Africa
- Latin America